Trade Mark Journal No.2026/046 13 November 2026

WO0000001934148 (5)

Office of origin: United States of America

Date of International Registration:11 June 2026
Date of designation in the UK: 11 June 2026
Image for mark 1934148 LEONABIO

International priority date claimed: 8 June 2026 (United States of America) (99871191)
Class 5
Pharmaceutical preparations for the treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for the prevention of cancer.

LeonaBio, Inc.

Representative: Kevin S. Costanza Seed Intellectual Property Law Group LLP, 701 5th Avenue, Suite 5400, Seattle WA 98104, UNITED STATES OF AMERICA